MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$52,675K
Free Cash flow
$42,733K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturity of investments
Other segment items
Payroll expense
Others
Negative Cash Flow Breakdown
Purchase of treasury stock
Inventories
Purchase of investments
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenues
-
171,171
719,887
-
Payroll expense
-
50,618
191,787
-
Materials and supplies
-
12,741
43,314
-
Clinical trials expense
-
1,552
3,038
-
Depreciation and amortization expense
-
14,348
56,695
-
Stock-based compensation expense
-
9,274
27,277
-
Consulting and outside services expense
-
10,362
39,771
-
Advertising and promotional expense
-
3,060
13,138
-
Other segment items
-
55,011
204,441
-
Interest income
-
2,400
8,679
-
Interest expense
-
6,553
25,481
-
Net revenues
-181,708
-
-
191,840
Payroll expense
-41,493
-
-
45,871
Materials and supplies
-6,103
-
-
7,648
Clinical trials expense
3,587
-
-
352
Depreciation and amortization expense
-13,695
-
-
14,129
Stock-based compensation expense
-4,708
-
-
6,297
Consulting and outside services expense
-6,377
-
-
9,922
Advertising and promotional expense
-3,229
-
-
3,374
Other segment items
-62,506
-
-
78,696
Interest income
-1,569
-
-
10,266
Interest expense
-5,639
-
-
6,284
Income tax provision
8,196
3,632
7,485
4,163
Net income
30,348
6,420
24,429
17,350
Loss on disposal of assets
-9
-4
-6
-1
(gain) loss on interest rate swaps and foreign currency transactions, net
879
416
-471
-285
Depreciation of property, plant, and equipment
8,042
8,078
8,071
7,860
Amortization of intangible assets
6,269
6,270
6,270
6,269
Operating lease right-of-use asset amortization
2,149
2,144
1,646
1,639
Amortization of discounts, premiums, and debt issuance costs
875
761
866
885
Share-based compensation expense
7,090
9,274
6,205
6,297
Changes in reserve for uncertain tax positions
-
-
-1,032
-
Changes in deferred taxes, net
-
-
-28,660
-
Accounts receivable, net
-2,979
4,547
-3,232
13,791
Inventories
9,879
-6,248
-9,009
-5,860
Prepaid expenses and other assets
2,543
2,326
-9,828
7,941
Income tax refunds, deposits, and payable, net
-7,105
-7,742
20,498
-4,122
Operating lease liabilities
-2,201
-1,415
-1,656
-1,591
Accounts payable and accrued liabilities
1,960
9,603
-42,644
25,338
Net cash provided by operating activities
51,324
47,840
32,863
52,583
Purchases and construction of property, plant, and equipment
8,591
9,507
8,272
5,348
Purchase of intangible assets
-
-
0
0
Purchase of investments
8,995
22,795
68,305
35,206
Maturity of investments
64,317
15,502
16,442
22,527
Deposits and other assets
1,861
-67
434
1,592
Net cash provided by investing activities
44,870
-16,733
-60,569
-19,619
Proceeds from equity plans, net of withholding tax payments
831
686
1,982
379
Purchase of treasury stock
45,213
29,492
20,516
4,850
Debt issuance costs
-
-
8
4
Proceeds from borrowing under lines of credit
-
-
273
172
Repayments under lines of credit
478
-
-
-
Principal payments on long-term debt
47
29
104
44
Net cash used in financing activities
-43,535
-30,207
-18,373
-4,347
Effect of exchange rate changes on cash
16
-138
-9
-41
Net increase in cash, cash equivalents, and restricted cash
52,675
762
-46,088
28,576
Cash, cash equivalents, and restricted cash at beginning of period
171,174
170,412
216,500
151,844
Cash, cash equivalents, and restricted cash at end of period
223,849
171,174
170,412
216,500
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
something is missing
$81,658K
Other segment items
-$62,506K
(-179.96%↓ Y/Y)
Payroll expense
-$41,493K
(-142.62%↓ Y/Y)
Depreciation and
amortization expense
-$13,695K
(-148.52%↓ Y/Y)
Consulting and outside
services expense
-$6,377K
(-135.73%↓ Y/Y)
Materials and supplies
-$6,103K
(-128.13%↓ Y/Y)
Interest expense
-$5,639K
(-144.87%↓ Y/Y)
Stock-based compensation
expense
-$4,708K
(-131.86%↓ Y/Y)
Advertising and promotional
expense
-$3,229K
(-146.29%↓ Y/Y)
Net income
$30,348K
(-46.11%↓ Y/Y)
Depreciation of property,
plant, and equipment
$8,042K
(-48.83%↓ Y/Y)
Income tax refunds,
deposits, and payable, net
-$7,105K
(-183.91%↓ Y/Y)
Share-based compensation
expense
$7,090K
(-52.01%↓ Y/Y)
Maturity of investments
$64,317K
(25.32%↑ Y/Y)
Canceled cashflow
$195,060K
Amortization of intangible
assets
$6,269K
(-49.88%↓ Y/Y)
Accounts receivable, net
-$2,979K
(28.94%↑ Y/Y)
Operating lease
right-of-use asset...
$2,149K
(-33.28%↓ Y/Y)
Accounts payable and
accrued liabilities
$1,960K
(-84.62%↓ Y/Y)
Amortization of discounts,
premiums, and debt...
$875K
(-45.45%↓ Y/Y)
Loss on disposal of
assets
-$9K
(71.88%↑ Y/Y)
Net cash provided by
operating activities
$51,324K
(-27.37%↓ Y/Y)
Net cash provided by
investing activities
$44,870K
(355.26%↑ Y/Y)
Canceled cashflow
$15,502K
Effect of exchange rate
changes on cash
$16K
(-93.85%↓ Y/Y)
Canceled cashflow
$19,447K
Net revenues
-$181,708K
(-152.68%↓ Y/Y)
Income tax provision
$8,196K
(-40.96%↓ Y/Y)
Clinical trials expense
$3,587K
(215.48%↑ Y/Y)
Interest income
-$1,569K
(60.87%↑ Y/Y)
Net increase in
cash, cash...
$52,675K
(46.00%↑ Y/Y)
Canceled cashflow
$43,535K
Inventories
$9,879K
(-72.51%↓ Y/Y)
Prepaid expenses and
other assets
$2,543K
(-53.06%↓ Y/Y)
Operating lease
liabilities
-$2,201K
(6.82%↑ Y/Y)
(gain) loss on interest
rate swaps and...
$879K
(150.63%↑ Y/Y)
Purchase of investments
$8,995K
(-42.41%↓ Y/Y)
Purchases and
construction of property,...
$8,591K
(-59.59%↓ Y/Y)
Deposits and other assets
$1,861K
(-20.30%↓ Y/Y)
Proceeds from equity
plans, net of...
$831K
(68.22%↑ Y/Y)
Net cash used in
financing activities
-$43,535K
(2.62%↑ Y/Y)
Canceled cashflow
$831K
Purchase of treasury
stock
$45,213K
(-9.97%↓ Y/Y)
Buy us a coffee
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)